Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy

Journal of Medical Virology

Volumn 69, Issue 3, 2003, Pages 401-407

  Gourlain, Karine ^a   Salmon, Dominique ^b   Gault, Elyanne ^c   Leport, Catherine ^d   Katlama, Christine ^a   Matheron, Sophie ^d   Costagliola, Dominique ^a   Mazeron, Marie Christine ^e   Fillet, Anne Marie ^a   Bloukli, N ^f   Chaput, S ^f   Deny P ^f   Freymuth, F ^f   Gozlan, J ^f   Houhou, H ^f   Lortholary, O ^f   Jarousse, B ^f   Berlureau, P ^f   Bentata, M ^f   Campa, P ^f   Gerbe J ^f   Gerard L ^f   Eid, Z ^f   Jadand, C ^f   Brun Vezinet F ^f   Lebeau, V ^f   Lebon, P ^f   Krivine, A ^f   Palmer, P ^f   Malkin, J E ^f   Semaille, C ^f   Jeantils, V ^f   Caron, C ^f   Salord, J M ^f   Badsi, E ^f   Cervoni, J ^f   Vincent, V ^f   Ait Mohand, H ^f   Huraux, J M ^f   Senechal B ^f   Meyohas, M C ^f   Bollens, D ^f   Gentil, G ^f   Gaujour, B ^f   Petit, P ^f   Boukli, N ^f   Molina, J M ^f   Ponscarme, D ^f   Martini, M ^f   Morinet, F ^f   Scieux, C ^f   Bazin, B ^f   Six, M ^f   Feret, P ^f   Bour, J B ^f   Borne, M C ^f   Micoud, M ^f   Leclercq, P ^f   Gailland, M C ^f   Seigneurin, J M ^f   Innocenti, P ^f   Raffi, F ^f   Allavena, C ^f   Billaudel, S ^f   Auger, S ^f   Imbert, B M ^f   Carquin, J ^f   Challine, D ^f   Dewilde, A ^f   Chenon, A ^f   Harzic, M ^f   Najiouhlah, F ^f   Mengelle, C ^f   Pothier, P ^f   Ranger Rogez, S ^f   Segondy, M ^f   Thouvenot, D ^f   more..

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Cochin Hospital ^*  (France)

^c AVICENNE HOSPITAL   (France)

^d BICHAT HOSPITAL   (France)

^e HÔPITAL LARIBOISIÈRE   (France)

^f Lariboisière Hospital ^*

Author keywords

Cytomegalovirus; HIV infected patients; Quantification; Relative PCR

Indexed keywords

ANTIVIRUS AGENT; VIRUS DNA;

ADULT; AGED; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; TAQ POLYMERASE;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 0037361059     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10303     Document Type: Article

References (17)

1. Alexandre I, Zammateo N, Ernest I, Ladrière JM, Hamels S, Chandelier N, Vipond B, Remacle J. 1998. Quantitative determination of CMV DNA using a combination of competitive PCR amplification and sandwich hybridisation. Biotechniques 25:676-683.
2. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debré P, Leibowitch J. 1997. Positive effects of combined antiretroviral therapy on CD4+ cell homeostasis and function in advanced HIV disease. Science 277:112-116.
3. Fleiss JL. 1981. The measurement of interrater agreement. In: Statistical methods for notes and proportion utility. New York: John Wiley and Sons. p 211-236.
4. Gault E, Michel Y, Dehee A, Belabani C, Nicolas JC, Garbarg-Chenon A. 2001. Quantitation of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol 39:772-775.
5. Gerard L, Leport C, Flandre P, Houhou N, Salmon-Céron D, Pepin JM, Mandet C, Brun-Vezinet F, Vilde JL. 1997. Cytomegalovirus (CMV) viremia and the CD4+ lymphocytes count as predictors of CMV disease in patients infected with human immunodeficiency virus. Clin Infect Dis 24:836-840.
6. Gulik RM. 2002. Structured treatment interruption in patients infected with HIV: a new approach to therapy. Drugs 62:245-253.
7. Heid CA, Stevens J, Livak KJ, Williams PM. 1996. Real time quantitative PCR. Genome Res 6:896-994.
8. Jacobson MA, Stanley H, Holtzer C, Margolis TP, Cunningham ET. 2000. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis 30:231-233.
9. Jacobson MA, Schrier R, McCune JM, Torriani FJ, Holland GN, O'Donnell JJ, Freeman WR, Bredt BM. 2001. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy. J Infect Dis 183:1399-1404.
10. Kearns AM, Draper B, Wipat W, Turner AJL, Wheeler J, Freeman R, Harwood J, Gould K, Dark JH. 2001. Light cycler-based quantitative PCR for detection of cytomegalovirus in blood, urine and respiratory samples. J Clin Microbiol 39:2364-2365.
11. Komanduri KV, Feinberg J, Hutchins RK, Frame RD, Schmidt DK, Viswanathan MN, Lalezari JP, McCune JM. 2001. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. J Infect Dis 183:1285-1289.
12. Laurendeau I, Bahuau M, Vodovar N, Larramendy C, Olivi M, Bieche I, Vidaud M, Vidaud D. 1999. TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. Clin Chem 45:982-998.
13. Mazeron MC, Costagliola D, Fillet AM, Salmon D, Gozlan J, Houhou N, Bour JB, Dény P, Imbert BM, Scieux C, Hassoun L, Sénéchal B, Freymuth F. 2000. Value of markers for cytomegalovirus (CMV) infection for the occurrence of CMV disease in human immunodeficiency virus (HIV) infected patients receiving highly active antiretroviral therapy: the Predivir study (P117). J Clin Virol 18:121-122.
14. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338:853-860.
15. Para MF, Kalish LA, Collier AC, Murphy EL, Drew WL. 2001. Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion. J Infect Dis 183:1673-1677.
16. Salmon-Céren D, Mazeron MC, Chaput S, Boukli N, Sénéchal B, Houhou N, Katlama C, Matheron S, Fillet AM, Gozlan J, Leport C, Jeantils V, Freymuth F, Costagliola D. 2000. Plasma cytomegalovirus DNA, pp65 antigenemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy. AIDS 14:1041-1049.
17. Yoshida A, Hitomi S, Fukui T, Endo H, Morisawa Y, Kazuyama Y, Osumi K, Oka S, Kimura S. 2001. Diagnosis and monitoring of human cytomegalovirus diseases in patients with human immunodeficiency virus infection by use of a real-time PCR assay. Clin Infect Dis 33:1756-1761.